These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32680987)

  • 21. Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma.
    Case A; Brisson BK; Durham AC; Rosen S; Monslow J; Buza E; Salah P; Gillem J; Ruthel G; Veluvolu S; Kristiansen V; Puré E; Brown DC; Sørenmo KU; Volk SW
    PLoS One; 2017; 12(7):e0180448. PubMed ID: 28683102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic landscape of breast cancer and mutation tracking with circulating tumor DNA in Chinese women.
    Wang Y; Lin L; Li L; Wen J; Chi Y; Hao R; Dai X; Chen Y; Huang D; Zhou Y; You J; Ye Z; Chen H; Jin L; Chen D; Yang F; Xia E; Ma X; Guo F; Tong Y; Zheng M; Wang O
    Aging (Albany NY); 2021 Apr; 13(8):11860-11876. PubMed ID: 33893247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
    Ordonez LD; Melchor L; Greenow KR; Kendrick H; Tornillo G; Bradford J; Giles P; Smalley MJ
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34003256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
    Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
    Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype.
    Valdés-Mora F; Salomon R; Gloss BS; Law AMK; Venhuizen J; Castillo L; Murphy KJ; Magenau A; Papanicolaou M; Rodriguez de la Fuente L; Roden DL; Colino-Sanguino Y; Kikhtyak Z; Farbehi N; Conway JRW; Sikta N; Oakes SR; Cox TR; O'Donoghue SI; Timpson P; Ormandy CJ; Gallego-Ortega D
    Cell Rep; 2021 Apr; 35(2):108945. PubMed ID: 33852842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells.
    Rädler PD; Wehde BL; Triplett AA; Shrestha H; Shepherd JH; Pfefferle AD; Rui H; Cardiff RD; Perou CM; Wagner KU
    Nat Commun; 2021 Jun; 12(1):3742. PubMed ID: 34145248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of lysyl oxidase as a marker for diagnosis of canine mammary tumors.
    Saleem A; Singh S; Sunil Kumar BV; Arora JS; Choudhary RK
    Mol Biol Rep; 2019 Oct; 46(5):4909-4919. PubMed ID: 31264163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.
    Van Keymeulen A; Lee MY; Ousset M; Brohée S; Rorive S; Giraddi RR; Wuidart A; Bouvencourt G; Dubois C; Salmon I; Sotiriou C; Phillips WA; Blanpain C
    Nature; 2015 Sep; 525(7567):119-23. PubMed ID: 26266985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes.
    Han B; Zhang H; Zhu Y; Han X; Wang Z; Gao Z; Yuan Y; Tian R; Zhang F; Niu R
    Aging (Albany NY); 2020 Jul; 12(13):13318-13337. PubMed ID: 32649310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.
    Jiang YZ; Ma D; Suo C; Shi J; Xue M; Hu X; Xiao Y; Yu KD; Liu YR; Yu Y; Zheng Y; Li X; Zhang C; Hu P; Zhang J; Hua Q; Zhang J; Hou W; Ren L; Bao D; Li B; Yang J; Yao L; Zuo WJ; Zhao S; Gong Y; Ren YX; Zhao YX; Yang YS; Niu Z; Cao ZG; Stover DG; Verschraegen C; Kaklamani V; Daemen A; Benson JR; Takabe K; Bai F; Li DQ; Wang P; Shi L; Huang W; Shao ZM
    Cancer Cell; 2019 Mar; 35(3):428-440.e5. PubMed ID: 30853353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers.
    Barrett MT; Lenkiewicz E; Malasi S; Basu A; Yearley JH; Annamalai L; McCullough AE; Kosiorek HE; Narang P; Wilson Sayres MA; Chen M; Anderson KS; Pockaj BA
    Breast Cancer Res; 2018 Jul; 20(1):71. PubMed ID: 29996881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
    Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
    Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
    Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
    Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
    Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J
    Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations.
    Abba MC; Zhong Y; Lee J; Kil H; Lu Y; Takata Y; Simper MS; Gaddis S; Shen J; Aldaz CM
    Oncotarget; 2016 Sep; 7(39):64289-64299. PubMed ID: 27588403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
    Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
    BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
    Klopfleisch R; Lenze D; Hummel M; Gruber AD
    BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis.
    Seung BJ; Cho SH; Kim SH; Lim HY; Sur JH
    PLoS One; 2020; 15(2):e0229031. PubMed ID: 32059046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling.
    Cheng H; Liu P; Ohlson C; Xu E; Symonds L; Isabella A; Muller WJ; Lin NU; Krop IE; Roberts TM; Winer EP; Arteaga CL; Zhao JJ
    Oncogene; 2016 Jun; 35(23):2961-70. PubMed ID: 26640141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.